Cell phone-based tech to allow at-home blood testing

Image
Press Trust of India New York
Last Updated : Mar 27 2018 | 5:00 PM IST

Scientists have developed a new cell phone-based blood testing technology that can provide immediate results in the comfort of one's home or a doctor's clinic.

Researchers at the University of South Florida in the US created a mobile version of the "Enzyme Linked Immunosorbent Assay" (ELISA), the gold standard technique used to detect the presence of an antibody or antigen.

Instead of sending patients to a laboratory, new cell phone-based technology allows for the very same test to be conducted in the doctor's office, clinic or even in a remote area.

"ELISA is an important technology for biochemical analysis of proteins and hormones and is critical for the diagnosis of many diseases, such as HIV and Lyme Disease," said Anna Pyayt, assistant professor at the University of South Florida.

"But the machines required for the incubation and reading are expensive and bulky. The MELISA allows patients to undergo testing and obtain results at point-of-care," said Pyayt, corresponding author of the study published in the journal Biosensors and Bioelectronics.

The Mobile Enzyme Linked Immunosorbent Assay (MELISA) device accurately measures progesterone levels, a key hormone that impacts female fertility and is indicative of some cancers.

MELISA consists of a water bath heater that incubates samples at a target temperature and analyses them via images taken by mobile phone.

It uses colour analysis to determine the RGB (red, green, blue) colour components of each sample.

The blue colour component is used for further analysis due to its sensitivity to the changes in progesterone concentration.

"It is designed to make biomedical testing simple and affordable. When low cost testing can be integrated with routine clinic visits, this would greatly improve the quality of healthcare and detect worrisome signs earlier," Pyayt said.

The portable MELISA weighs just one pound, dramatically helping older patients suffering chronic conditions and those across the world.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 27 2018 | 5:00 PM IST

Next Story